MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2A. (Q52576485)
Jump to navigation
Jump to search
scientific article published in April 2018
Language | Label | Description | Also known as |
---|---|---|---|
English | MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2A. |
scientific article published in April 2018 |
Statements
MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2A (English)
Robert H Baloh
Emmanouil Zacharioudakis
Jeanne M Rumsey
Justin M Alberti
William C Knight
R Reid Townsend
1 reference
1 reference